Honeywell Advanced Materials, a world leader in the development, manufacture and supply of refrigerants, is committed to helping customers achieve their sustainability goals. Honeywell has invested a billion dollars in research, development, and new capacity for Solstice® HFO technology to help businesses transition to lower-carbon future by converting from high global warming potential hydrofluorocarbons (HFCs) to Solstice® hydrofluoroolefin (HFO) technology.

Solstice® helps customers lower their carbon footprint and improve energy efficiency without sacrificing end-product performance. Worldwide adoption of Solstice® products has resulted in the reduction of more than 200 million metric tons of CO2 to date, equal to eliminating the emissions from more than 42 million cars.

Solstice® Air is a breakthrough medical propellant currently in clinical development for pressurized metered dose inhalers (pMDIs) with the ability to help reduce greenhouse gas emissions. A near-zero global warming potential (GWP) alternative to hydrofluoroalkanes, Solstice® Air is non-flammable (per ASTM E-681 and ISO 10156), non-ozone depleting, and VOC-exempt (U.S. EPA and CARB).